Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 815 results for "usfda"

USFDA warns of Dr Reddy's drug import ban if flaws are not fixed
Financial Express

US FDA extends 2 weeks deadline for Dr. Reddy's response on qu...

The United States Food and Drugs Administration (USFDA), which had issued a 15 days deadline to respond to its warning letters issued to Dr. Reddy's laboratories has extended it to 2 weeks more till December 7. With USFDA issued warnings to 3 ... PharmaBiz, 3 days ago
Dr Reddy's gets USFDA extension for its response Financial Express, 4 days ago

Lupin to get booster from USFDA nod

Shares of Lupin will remain in focus, following the company receiving approval from the USFDA for its generic version of Warner Chilcott's oral contraceptive tablets Loestrin in two strengths. Lupin Pharmaceuticals Inc would shortly commence ...
 Hindu Business Line6 days ago Lupin receives USFDA nod for generic loestrin tablets  MyIris6 days ago Lupin gets USFDA's approvals for generic Loestrin Fe 1/20 and Loestrin 1.5/30 tablets  Finalaya.com6 days ago Aurobindo gets green signal from USFDA for Sildenafil tablets  HT Syndication1 week ago
Financial Express

Dr Reddy's Lab shares fall over 8% on USFDA warning, should you buy?

Dr Reddy's share price slumped over9 per cent intraday on Thursday after the United States Food and Drug Administration (USFDA) warned homegrown pharma major that if the company fails to take corrective actions at three of its manufacturing ...
 Financial Express4 days ago Dr Reddy's tanks 10% on USFDA warning: How to trade now?  Moneycontrol.com4 days ago Dr Reddy's slumps 10% on worries over import ban  Hindu Business Line4 days ago Dr Reddy's Lab tumbles 6% on USFDA warning  MyIris5 days ago

Dr Reddy's slumps after USFDA warns of ban on certain facilities sighting violations of global practices

Dr Reddy's Laboratories dropped 6.2% to Rs 3,178.05 at 11:50 IST on BSE after the USFDA in its warning letter stated it may ban all products made at certain facilities of the company unless they conform to prescribed global manufacturing standards. ...
 Capital Market4 days ago USFDA warns of serious data integrity violations at Dr Reddy's  Financial Express5 days ago Warning letter: USFDA flags serious violations at Dr Reddy's  Indian Express5 days ago USFDA warning letter flags serious breaches at Dr.Reddy's  Livemint.com5 days ago

Strides Arcolab shares gain on receiving USFDA approval for Dutasteride Softgel Capsule

At 2.11 pm, the share price Strides Arcolab was up 0.86 per cent at Rs 1,374.55. The scrip opened at Rs 1390 and had touched a high and low of Rs 1412.45 and Rs 1368.80, respectively, in trade so far. (Express Photo) Shares of Strides Arcolab ...
 Financial Express1 week ago Strides Shasun shares up 3% intraday on USFDA approval  DNA India1 week ago Strides Shasun shines on receiving USFDA approval for Dutasteride Softgel Capsule  Finalaya.com1 week ago Strides Shasun receives USFDA approval for Dutasteride...  Bio Spectrum Asia6 days ago
Business Standard India

Dr Reddy's says preparing response to USFDA warning

Email this Print Dr Reddy's Laboratories said the company is in the process of responding to the warning letter issued on November 5 by the US Food and Drug Administration (USFDA) over quality control issues and other violations at three of its ...
 Smart Investor4 days ago USFDA warning: Have 15 days to respond, says DRL CFO  Moneycontrol.com3 weeks ago
Financial Express

Dishman Pharma surges 6% on clarification for receipt of USFDA warning letter

NEW DELHI: Shares of Dishman Pharmaceuticals surged over 5 per cent in Wednesday's trade after the company clarified on the news relating to a warning letter from the US drug regulator on the Clovis issue. In a statement released to the bourses, ...
 Economic Times1 week ago Not received warning from USFDA on Clovis: Dishaman Pharma  Moneycontrol.com1 week ago Dishman Pharma shares climb after clarification on USFDA warning  Financial Express1 week ago Dishman slumps 14%; USFDA seeks clarity on Clovis' drug  Business Today India1 week ago

New Drug "Ninlaro" Receives USFDA Approval for Treating Multiple Myeloma

Takeda Oncology, a drug firm has received USFDA approval for its new drug called "ninlaro" as part of the combination treatment for Multiple Myeloma. The drug ixazomib marketed as ninlaro can be administered along with Celgene's Revlimid ...
 MedIndia1 week ago 4 in 1 Combination Pill Receives USFDA Approval for HIV Treatment  MedIndia3 weeks ago FDA approves new drug with fewer side effects  Times of India2 weeks ago

Dr Reddy's dips as USFDA warns import ban

Dr Reddy's Laboratories has dipped 10% to Rs 3,050 on the BSE in early morning trade on reports that the United States Food and Drug Administration (USFDA) said it might withhold approval of the company's fresh drugs and stop import if no corrective ...
 Smart Investor5 days ago
Business Standard India

USFDA finds lack of production records, back-dated logs at Sandoz unit

The US Food and Drugs Administration (USFDA) found absence of production and control records and lack of written procedures to prevent contamination of products at Sandoz's manufacturing units near Mumbai.Sandoz is the generic drug division of ...
 Smart Investor5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - usfda
Get updated on latest news & your favorite topics right in your inbox!
More     Less